A carregar...
Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy
Despite the promising antilymphoma activity of histone deacetylase (HDAC) inhibitors as a drug class, resistance is a significant clinical issue. Elucidating the molecular mechanisms driving HDAC inhibitor resistance and/or the specific targets that are altered in drug-resistant cells may facilitate...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594386/ https://ncbi.nlm.nih.gov/pubmed/33108458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002297 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|